SolarEdge Technologies to See Continued Solar Revenue, Margin Growth, RBC Capital Markets Says
MT newswire2026/09/11 15:05Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
11:05 AM EDT, 09/11/2026 (MT Newswires) -- SolarEdge Technologies' (SEDG) outlook points to continued revenue and margin growth in its core solar business, helped by operational improvements, its Nexis platform and higher battery energy storage system attachment rates, RBC Capital Markets said in a note Friday. Management's guidance of $2.4 billion in 2029 revenue, including $1.8 billion from its core solar business and $600 million from solid-state transformers, highlights a potentially significant longer-term opportunity, with gross margin expected to reach about 35% by 2029, according to the note. The company's solid-state transformer technology for artificial intelligence data centers offers a "compelling" value proposition, but the investment firm said more evidence of commercial adoption is needed given competitive risks. RBC said it models $300 million of transformer revenue in 2029. The firm said it also expects the Nexis platform to support higher solar sales and margins, while $1.7 billion in firm safe harbor inverter orders provides additional demand visibility. RBC raised its price target to $30 from $24, and has a sector perform, speculative risk rating on SolarEdge Technologies. Price: 36.62, Change: -0.13, Percent Change: -0.37
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Descartes Q2 Tops Expectations as Acquisitions, AI Investments Support Growth, RBC Says
MT newswire•2026/09/11 15:34
Oncoclínicas corrects filing, says arbitration request was submitted Aug. 21, not yet initiated
Reuters•2026/09/11 15:33
Definium Therapeutics' Upcoming Phase 3 Data on DT120 to De-Risk Program, Back FDA Approval, RBC Says
MT newswire•2026/09/11 15:33
Crypto prices
MoreBitcoin
BTC
$78,682.23
+2.05%
Ethereum
ETH
$2,608.52
+7.12%
Tether USDt
USDT
$0.9997
+0.02%
BNB
BNB
$734.48
+3.89%
XRP
XRP
$1.4
+3.16%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$103.37
+3.69%
TRON
TRX
$0.3363
-0.72%
Hyperliquid
HYPE
$83.14
+3.08%
Zcash
ZEC
$1,199.65
+2.80%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now